About Us
Cardiovascular-kidney-metabolic (CKM) disease - where heart disease, chronic kidney disease (CKD), diabetes and obesity co-exist and exacerbate each other - affects over 1 billion people worldwide, and is a growing public health emergency placing increasing strain on healthcare services.
While there is no cure, helping people with CKM conditions to increase their physical activity levels and improve their lifestyles can have a significant impact on health outcomes.
That is why co-founders Katie Bell, a tech entrepreneur, and Professor Sharlene Greenwood, a consultant physiotherapist and exercise professor, came together to create Beam.
Our mission is to improve the physical and mental health of all people with cardiovascular, kidney and metabolic conditions, helping to make healthcare more preventative, lower the cost of delivering care and improve patient outcomes for people with CKM disease all around the world.
Our awards and commendations
-
![HSJ Digital Awards 2025]()
Finalist - "Optimising Clinical Pathways Through Digital”
-
![]()
Finalist - "Best Digital Health Product"
-
![Digital Health.London Accelerator]()
Winner - “Company Generating the Greatest NHS Benefit”
-
![HTN Now Awards 2025]()
Highly Commended - “Digital Patient Transformation”
-
![HTN Now Awards - Finalist]()
Finalist - “Health Tech Case Study of the Year” and “SME/Start Up Innovation”
Our leadership team
-
Katie Bell
Co-Founder, CEO
Socially-driven tech entrepreneur, passionate about building products that improve lives
Full Bio | LinkedIn
-
Professor Sharlene Greenwood
Co-Founder, CMO
Consultant physiotherapist, leading voice in exercise therapy for kidney patients
Full Bio | LinkedIn
-
Jamie Starr
Marketing Director
Experienced healthtech & digital communications professional with a focus on innovation
Full Bio | LinkedIn
-
Lucy Sreeves
Board Member
Chief income and engagement officer for leading charity Kidney Research UK
Full Bio | LinkedIn
-
Simon Loopuit
Commercial Advisor
-
Pamela Scarborough
Advisor
-
Ashley Duqué Kienzle
Advisor
Our advisory board
-
Stephen Bourne
Expert in fostering collaboration between pharma, healthcare and biotech organisations, with a focus on renal medicine.
Full Bio | LinkedIn
-
Gill Manning
Highly skilled Scientific Advisor with a portfolio that spans prestigious pharmaceutical companies, key healthcare providers, public bodies and charitable work.
Full Bio | LinkedIn
-
Elizabeth Egan
Dynamic CEO, NED, and business leader with a proven record of driving growth across global markets. Ex AstraZeneca and Weight Watchers.
Full Bio | LinkedIn
-
Irina Osovskaya
Highly experienced across senior R&D, Commercial, and IT roles. A recognised leader in Digital Health and AI. Ex AstraZeneca and Johnson & Johnson.
Full Bio | LinkedIn
Contact us
Interested in working together? Fill out some info on our contact us page and we will be in touch shortly. We can’t wait to hear from you!